Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
WARNER-LAMBERT COMPA, et al v. PUREPAC PHARMACEUTIC, et al
Case Number:
2:00-cv-02931
Court:
Nature of Suit:
Judge:
Firms
- Axinn Veltrop
- Bevan Mosca
- Connell Foley
- Duane Morris
- Faegre Drinker
- Farney PC
- Haug Partners
- Hill Wallack
- Hunton Andrews
- Kenyon & Kenyon
- Lite DePalma
- Marino Tortorella
- McCarter & English
- Parker Ibrahim
- Patunas Law
- Robinson Miller
- Saiber LLC
- Santomassimo Davis
Companies
Sectors & Industries:
-
May 31, 2011
Pfizer Ends Patent War Over Generic Neurontin
Pfizer Inc. on Tuesday dropped the remaining defendants from a long-running patent infringement suit in New Jersey over generic versions of the epilepsy drug Neurontin.
-
May 03, 2011
Pfizer, Eon Settle Neurontin Patent Claims
Pfizer Inc. agreed Thursday to drop Eon Labs Inc. from a long-running patent infringement suit in New Jersey over a generic version of the epilepsy drug Neurontin.
-
April 06, 2011
Jury To Weigh Lost Profits In Neurontin Patent Fight
A New Jersey federal judge ruled Monday that a jury should decide whether Pfizer Inc. is entitled to lost profits in its long-running patent infringement case against several generics makers over epilepsy drug Neurontin.